# Aeluma, Inc.: overview ALMU · Nasdaq · CIK 1828805 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/almu.md) · [Financials](/companies/almu/financials.md) · [Filings](/companies/almu/filings.md) · [Insiders](/companies/almu/insiders.md) Latest reported revenue: [$582.0k](/filings/0001213900-26-100584.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 16, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-100584). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [481](/filings/0001213900-25-109328.md) | [1,612](/filings/0001213900-26-014999.md) | [1,255](/filings/0001213900-26-055956.md) | [1,317 d](/filings/0001213900-26-100584.md) | [1,385](/filings/0001213900-25-109328.md) | [1,272](/filings/0001213900-26-014999.md) | [1,222](/filings/0001213900-26-055956.md) | [582 d](/filings/0001213900-26-100584.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(152.0%)](/filings/0001213900-25-109328.md) | [24.1%](/filings/0001213900-26-014999.md) | [(166.3%)](/filings/0001213900-26-055956.md) | [180.7% d](/filings/0001213900-26-100584.md) | [(116.1%)](/filings/0001213900-25-109328.md) | [(163.6%)](/filings/0001213900-26-014999.md) | [(273.9%)](/filings/0001213900-26-055956.md) | [(84.7%) d](/filings/0001213900-26-100584.md) | | Net margin | % | [(151.8%)](/filings/0001213900-25-109328.md) | [(179.6%)](/filings/0001213900-26-014999.md) | [116.4%](/filings/0001213900-26-055956.md) | [(65.1%) d](/filings/0001213900-26-100584.md) | [(107.8%)](/filings/0001213900-25-109328.md) | [(145.7%)](/filings/0001213900-26-014999.md) | [(147.3%)](/filings/0001213900-26-055956.md) | [(689.5%) d](/filings/0001213900-26-100584.md) | | Diluted EPS | $ per share | [(0.06)](/filings/0001213900-25-109328.md) | [(0.24)](/filings/0001213900-26-014999.md) | [0.11](/filings/0001213900-26-055956.md) | not reported | [(0.09)](/filings/0001213900-25-109328.md) | [(0.11)](/filings/0001213900-26-014999.md) | [(0.10)](/filings/0001213900-26-055956.md) | not reported | | Free cash flow | $k | [(933)](/filings/0001213900-25-109328.md) | [(440) d](/filings/0001213900-26-014999.md) | [205 d](/filings/0001213900-26-055956.md) | [(141) d](/filings/0001213900-26-100584.md) | [(1,025)](/filings/0001213900-25-109328.md) | [(282) d](/filings/0001213900-26-014999.md) | [(775) d](/filings/0001213900-26-055956.md) | [(1,830) d](/filings/0001213900-26-100584.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | [193](/filings/0001213900-24-082694.md) | [919](/filings/0001213900-25-086227.md) | [4,665](/filings/0001213900-26-100584.md) | [4,461](/filings/0001213900-26-100584.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | [(2849.8%)](/filings/0001213900-24-082694.md) | [(496.5%)](/filings/0001213900-25-086227.md) | [(45.9%)](/filings/0001213900-26-100584.md) | [(228.3%)](/filings/0001213900-26-100584.md) | | Net margin | % | not reported | [(2782.5%)](/filings/0001213900-24-082694.md) | [(496.4%)](/filings/0001213900-25-086227.md) | [(64.8%)](/filings/0001213900-26-100584.md) | [(205.3%)](/filings/0001213900-26-100584.md) | | Diluted EPS | $ per share | [(0.32)](/filings/0001213900-23-078910.md) | [(0.47)](/filings/0001213900-24-082694.md) | [(0.37)](/filings/0001213900-25-086227.md) | [(0.23)](/filings/0001213900-26-100584.md) | [(0.52)](/filings/0001213900-26-100584.md) | | Free cash flow | $k | not reported | [(4,228)](/filings/0001213900-24-082694.md) | [(3,777)](/filings/0001213900-25-086227.md) | [(1,309)](/filings/0001213900-26-100584.md) | [(3,912)](/filings/0001213900-26-100584.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/almu/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $21.5m | 973,235 | | Added +113,528 | | [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $17.6m | 797,983 | | Added +772,983 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $12.7m | 574,417 | | Reduced −14,334 | | [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $11.7m | 529,005 | | Added +130,706 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.0m | 318,018 | | Added +22,696 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $5.6m | 254,168 | | Added +6,823 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $4.6m | 208,000 | Call | Added +144,000 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $4.4m | 198,000 | Put | Added +124,800 | | [Apis Capital Advisors, LLC](/funds/1386892.md) | 2026-06-30 | $4.3m | 194,000 | | Reduced −12,000 | | [AWM Investment Company, Inc.](/funds/1535264.md) | 2026-06-30 | $2.9m | 131,404 | | Reduced −68,596 | ## Recent filings [All 264 filings](/companies/almu/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 17:00 ET | [8-K](/filings/0001213900-26-111607.md) | 8.01 Other events | 0001213900-26-111607 | | 2026-09-30 | 20:08 ET | [DEF 14A](/filings/0001213900-26-105227.md) | Proxy statement, period 2026-11-19 | 0001213900-26-105227 | | 2026-09-30 | 20:01 ET | [8-K](/filings/0001213900-26-105210.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-105210 | | 2026-09-16 | 21:15 ET | [10-K](/filings/0001213900-26-100584.md) | Annual report, period 2026-06-30 | 0001213900-26-100584 | | 2026-09-16 | 20:45 ET | [8-K](/filings/0001213900-26-100546.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-100546 | | 2026-07-30 | 01:37 ET | [8-K](/filings/0001213900-26-083005.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-083005 | | 2026-05-19 | 13:00 ET | [8-K](/filings/0001213900-26-058750.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058750 | | 2026-05-13 | 21:23 ET | [10-Q](/filings/0001213900-26-055956.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055956 | | 2026-05-13 | 20:45 ET | [8-K](/filings/0001213900-26-055893.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-055893 | | 2026-03-20 | 21:05 ET | [8-K](/filings/0001213900-26-032426.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-032426 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001213900-26-100584.md), filed Sep 16, 2026. ## Forecast league Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/567f907d-c5cb-48c5-8df9-eebcfa23996c) ## About the filer - CIK: 1828805 - Tickers: ALMU - Exchange: Nasdaq - SIC code: 3674 Semiconductors & Related Devices - State of incorporation: DE - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.